Clinical trial • Not applicable • Neurology

Clinical trial in Amyotrophic lateral sclerosis

Not applicable trial for Amyotrophic lateral sclerosis. 23 participants.

Overview

Trial Therapeutic Area
Neurology
Trial Disease
Amyotrophic lateral sclerosis
Trial Stage
Not applicable

Key dates

Initial CTIS Submission Date
06-12-2024
First CTIS Authorization Date
19-03-2025

Trial design

Not applicable trial across 3 sites in France.

Target Sample Size
23
Trial Duration For Participant
1461

Eligibility

Recruits 23 No vulnerable population selected (isVulnerablePopulationSelected=false).

Vulnerable Population
No vulnerable population selected (isVulnerablePopulationSelected=false)

Recruitment

Planned Sample Size
23
Recruitment Window Months
48

Geography

Total Number Of Sites
3
Total Number Of Participants
23

France

Earliest CTIS Part Ii Submission Date
17-03-2025
Latest Decision Or Authorization Date
10-04-2026
Processing Time Days
389
Number Of Sites
3
Number Of Participants
23

Sites

Site Name
Assistance Publique Hopitaux De Paris
Department Name
Neurology DepartmentClinical Investigation Center
Principal Investigator Name
Gaelle BRUNETEAU
Principal Investigator Email
gaelle.bruneteau@aphp.fr
Contact Person Name
Gaelle BRUNETEAU
Contact Person Email
gaelle.bruneteau@aphp.fr
Site Name
Assistance Publique Hopitaux De Paris
Department Name
Neurosurgery
Principal Investigator Name
Alexandre CARPENTIER
Principal Investigator Email
alexandre.carpentier@aphp.fr
Contact Person Name
Alexandre CARPENTIER
Contact Person Email
alexandre.carpentier@aphp.fr
Site Name
Assistance Publique Hopitaux De Paris
Department Name
Neurology Department
Principal Investigator Name
Gaelle BRUNETEAU
Principal Investigator Email
gaelle.bruneteau@aphp.fr
Contact Person Name
Gaelle BRUNETEAU
Contact Person Email
gaelle.bruneteau@aphp.fr

Sponsor

Primary sponsor

Full Name
Assistance Publique Hopitaux De Paris
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
France

Related trials

Other published trials that may interest you.